Results 1 to 10 of about 148,693 (120)

Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir

open access: yesPharmaceuticals, 2023
In 2019, EMA licensed intravenous (IV) zanamivir for severe influenza virus infection in children over 6 months as well as adults. Prior to that, it was possible via a compassionate use program.
Maren Alchikh   +3 more
doaj   +1 more source

No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination

open access: yesVaccine: X, 2019
Influenza is a contagious respiratory illness caused by the influenza virus. The pandemic outbreak of influenza A H1N1 in 2009 (H1N1pdm09) gave us a unique opportunity to study humoral immune responses to a novel influenza vaccine strain.
Anders Madsen   +6 more
doaj   +1 more source

Influenza Vaccines toward Universality through Nanoplatforms and Given by Microneedle Patches

open access: yesViruses, 2020
Influenza is one of the top threats to public health. The best strategy to prevent influenza is vaccination. Because of the antigenic changes in the major surface antigens of influenza viruses, current seasonal influenza vaccines need to be updated every
Sijia Tang, Wandi Zhu, Bao-Zhong Wang
doaj   +1 more source

Endocytosis Deficient Murine Xcl1-Fusion Vaccine Enhances Protective Antibody Responses in Mice

open access: yesFrontiers in Immunology, 2019
Targeting antigen to surface receptors on dendritic cells (DCs) can improve antibody response against subunit vaccines. We have previously observed that human XCL1-fusion vaccines target murine Xcr1+ DCs without actively inducing endocytosis of the ...
Arnar Gudjonsson   +5 more
doaj   +1 more source

H7N9 Incident, immune status, the elderly and a warning of an influenza pandemic

open access: yesJournal of Infection in Developing Countries, 2013
The novel re-assortment A influenza H7N9 (nrH7N9) emerged in humans in the Shanghai and surrounding provinces of China in late February and early March.
Yi Guan   +5 more
doaj   +1 more source

Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity

open access: yesVaccines, 2021
Influenza poses a huge threat to global public health. Influenza vaccines are the most effective and cost-effective means to control influenza. Current influenza vaccines mainly induce neutralizing antibodies against highly variable globular head of ...
Zhuofan Li   +3 more
doaj   +1 more source

The interplay between susceptibility and vaccine effectiveness control the timing and size of an emerging seasonal influenza wave in England

open access: yesEpidemics, 2023
Relaxing social distancing measures and reduced level of influenza over the last two seasons may lead to a winter 2022 influenza wave in England. We used an established model for influenza transmission and vaccination to evaluate the rolled out influenza
E. van Leeuwen   +4 more
doaj   +1 more source

Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory Confirmed Influenza in 2014-2015 Season in Turkey: A Test-Negative Case Control Study

open access: yesBalkan Medical Journal, 2018
Background: Influenza has an important public health impact worldwide with its considerable annual morbidity among persons with or without risk factors and its serious complications among persons in high-risk groups.
Can Hüseyin Hekimoğlu1   +5 more
doaj   +1 more source

Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Objectives: The current study aimed to evaluate the prevalence, level of knowledge and attitudes to seasonal influenza vaccination among older adults in Jordan.
Mera Ababneh   +3 more
doaj   +1 more source

A typology of beliefs and misperceptions about the influenza disease and vaccine among older adults in Singapore.

open access: yesPLoS ONE, 2020
Access to the influenza vaccine pose little barriers in developed countries such as Singapore and vaccination against influenza is highly recommended for at-risk populations including older adults.
Christopher L Cummings   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy